Articles From: Savient Pharmaceuticals Announces Abstract Related To KRYSTEXXA® Accepted For Presentation At ASN Kidney Week 2013 to Vical Publication Highlights Milestone in Vaccine Development

2014/2/3 MARKHAM, ONTARIO --
Sign-up for Leisureworld Q4 2013 Results Release, New Conference Call Time and Webcast investment picks
With Game Day Quickly Approaching, the Tostitos Brand is Bringing the Party with New Fajita Flavored Scoops! Tortilla Chips and Tostitos Queso Blanco Dip PLANO, Texas , Dec.
Sign-up for The Tostitos Brand And Superstar Nelly Get Fans Amped Up For The 2014 Tostitos Fiesta Bowl investment picks
Sign-up for RealNetworks To Release 4th Quarter Results February 5 investment picks
- Data presented today at the American Heart Association - Isis hosting webcast tomorrow, November 19 at 7:15 a.m. CT at CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Reports Fifth Positive Phase 2 Data Set for ISIS-APOCIII Rx Showing Significant Reductions in Triglyceride and ApoC-III Levels investment picks
2014/1/30 SUNNYVALE, CA --
Sign-up for NetApp Hosts Third Quarter Fiscal Year 2014 Financial Results Webcast investment picks
Sign-up for Millennium Management 3Q 13F: Largest Eliminations -2- investment picks
(NYSE:MANU) English Premier League football club, Manchester United and prestigious global watchmaker, Bulova have today announced a three year sponsorship agreement to become the Club’s Official Timekeeper and Global Partner.
Sign-up for Manchester United and Bulova Announce Global Partnership investment picks
Merck (NYSE:MRK), known as MSD outside the United States and Canada, said today it has started a rolling submission to the U.S. Food and Drug Administration (FDA) of a Biologics License Application for MK-3475, the company’s investigational anti-PD-1 immunotherapy, for patients with advanced melanoma who have been previously treated with ipilimumab.
Sign-up for Merck Initiates Rolling Submission of U.S. Biologics License Application for MK-3475, an Investigational Anti-PD-1 Immunotherapy, in Patients with Advanced Melanoma investment picks
Sign-up for First Quantum Minerals Declares an Interim Dividend of Cdn $0.0583 Per Share investment picks
Time Warner Cable Inc. (NYSE:TWC) today announced that Executive Vice President and Chief Financial Officer Artie Minson will participate in the Citi 2014 Internet, Media & Telecommunications Conference on Wednesday, January 8, 2014, in Las Vegas.
Sign-up for Time Warner Cable’s Executive Vice President and Chief Financial Officer Artie Minson to Participate in the Citi Internet, Media & Telecommunications Conference investment picks
Myriad Genetics Inc. said it has agreed to acquire Crescendo Bioscience Inc., for $270 million in cash, as it reported a 43.7% rise in fiscal second-quarter net profit.
Sign-up for Myriad Genetics to Buy Crescendo Bioscience investment picks
Sign-up for Straight Path Communications To Hold General Business Update Conference Call On January 9, 2014 investment picks
Sign-up for Bladex Announces Quarterly Dividend Payment for Fourth Quarter 2013 investment picks
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that the U.S. Food and Drug Administration (FDA) has accepted and filed for review the company’s Biologics License Application (BLA) for Natpara ® (recombinant human parathyroid hormone 1-84, (rhPTH[1-84])) for the treatment of hypoparathyroidism.
Sign-up for NPS Pharmaceuticals Announces FDA Acceptance of Biologics License Application for Natpara® for the Treatment of Hypoparathyroidism investment picks
Marvell's Broad Patent Portfolio Recognized by Leading Global Media SANTA CLARA, Calif.
Sign-up for Marvell Named a Thomson Reuters 2013 Top 100 Global Innovator for the Second Consecutive Year investment picks
Agreement represents important step toward resolution of legacy issues TROY, Mich.
Sign-up for Flagstar Reaches Settlement with Fannie Mae over Mortgage Repurchase Obligations investment picks BLAINE, WA --
Sign-up for Hollund Industrial Marine Announces Progress Update on Bayano Lake Project investment picks
Officials with Humana Inc. (NYSE: HUM) and Humana Pharmacy Solutions, Inc. celebrated the opening today of a state-of-the-art RightSource® mail-order pharmacy call center and support operation in Irving.
Sign-up for Humana Celebrates Opening of Mail-Order Pharmacy Facility in Irving investment picks
Legacy Oil + Gas Inc. announces 2014 budget and public guidance Canada NewsWire At recent strip pricing and 2013 average differentials, this budget is expected to deliver cash flow in excess of $355 million , or $2.27 per basic common share, an increase of over 21 percent over 2013 expected cash flow per share.
Sign-up for Legacy Oil + Gas Inc. announces 2014 budget and public guidance investment picks
MIAMI , Nov.
Sign-up for Royal Caribbean Announces Allure of the Seas Will Undergo Repairs in February 2014 investment picks
Sign-up for Perfumania Holdings, Inc. Reports Perfumania Retail Sales for Second Quarter Ended July 2013 investment picks
Sign-up for R/GA and Techstars Launch "Connected Devices" Accelerator investment picks
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- After another record-setting day for the S&P 500 index, U.S. stock futures pointed to a softer open on Wednesday as investors prepared for a string of earnings reports, including Dow components Boeing Co.
Sign-up for UPDATE: Stock futures retreat with Boeing, CAT on tap investment picks
Both International ProStar with ISX15 and TerraStar 4x4 awarded NEW ORLEANS , Jan.
Sign-up for Navistar Sweeps 2014 ATD Truck of the Year Honors investment picks
TurboTax®, the nation’s leading online tax preparation service from Intuit Inc. (Nasdaq: INTU) is now rewarding customers for recommending TurboTax to their friends and family.
Sign-up for Intuit TurboTax Launches New Refer-A-Friend Program investment picks
Sign-up for Vical Publication Highlights Milestone in Vaccine Development investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar

Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Savient Pharmaceuticals Announces Abstract Related To KRYSTEXXA® Accepted For Presentation At ASN Kidney Week 2013 to Vical Publication Highlights Milestone in Vaccine Development
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity